Abiopharma

🔍 Reilly Joseph James (Executive)

Company: ARDELYX, INC. (ARDX)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Sold 2,872 shares of Common Stock at $3.8569 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 146,964.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,110 shares of Common Stock at $3.8569 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 145,854.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• REMARKS: Senior Vice President and Chief Accounting Officer